Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …

Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women
throughout the world. Approximately two thirds of the patients are diagnosed with locally …

Introduction: Cervical cancer (CC) is currently the fourth most common malignant disease of
women worldwide. Although the incidence and the mortality rates have been decreasing …

Effective cytotoxic treatment options for advanced cervical cancer are exceedingly limited.
Cisplatin-based combination chemotherapy, the most commonly used cytotoxic therapy, has …

Cervical cancer is the third most common cancer worldwide, and the development of new
diagnosis, prognostic, and treatment strategies is a major interest for public health. Cisplatin …

It is estimated that 604,127 patients were diagnosed with cervical cancer worldwide in 2020.
While a small percentage of patients will have metastatic disease at diagnosis, a large …

Cervical cancer is the leading gynecologic health problem which is considered as the 4th
most widespread tumour in women. The prevalence of this fatal ailment is emerging …

Purpose The purpose of this study was to provide an overview of current and up and coming
targeted therapies in cervical cancer with or without chemotherapy. Methods We reviewed …

Cervical cancer is the third most commonly diagnosed cancer worldwide and the fourth
leading cause of cancer death in women. Major advances but still insufficient achievements …

Introduction: There is a shortage of therapeutical agents for invasive cervical cancer in late
stages of development; however, a number of promising molecules are currently in early …